Copyright
©The Author(s) 2018.
World J Obstet Gynecol. Jul 10, 2018; 7(1): 1-16
Published online Jul 10, 2018. doi: 10.5317/wjog.v7.i1.1
Published online Jul 10, 2018. doi: 10.5317/wjog.v7.i1.1
Women over the age of 30 |
Family history of autoimmune thyroid illness or hypofunction |
Women with thyroid swelling |
Women with thyroid antibodies (mainly TPO) |
Symptoms or signs indicative of hypothyroidism |
Women with T1DM, or with any autoimmune diseases |
Women with previous history of abortion and premature birth |
Women with history of previous head or neck radiation or thyroidectomy |
Women on thyroid hormones replacement therapy |
Women living in a geographical area lacking iodine |
The condition sought should be an important health problem |
There should be an accepted treatment for patients with recognised disease |
Facilities for diagnosis and treatment should be available |
There should be a latent or early symptomatic stage |
There should be a suitable test or examination |
The test should be acceptable to the population |
The natural history of the condition should be adequately understood |
There should be an agreed policy on who to treat as patients |
The cost of case finding should be cost-effective |
Case finding should be a continuing process and not a “once and for all” project |
- Citation: Mirghani Dirar A, Kalhan A. Hypothyroidism during pregnancy: Controversy over screening and intervention. World J Obstet Gynecol 2018; 7(1): 1-16
- URL: https://www.wjgnet.com/2218-6220/full/v7/i1/1.htm
- DOI: https://dx.doi.org/10.5317/wjog.v7.i1.1